南京科佰生物科技有限公司

主營產(chǎn)品: atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買

11

聯(lián)系電話

18066071954

您現(xiàn)在的位置: 南京科佰生物科技有限公司>>藥靶細(xì)胞株>>腫瘤免疫細(xì)胞株>> CBP74063ICOS Effector Reporter Cell

公司信息

聯(lián)人:
蔣經(jīng)理
話:
4008750250
機:
18066071954
真:
址:
南京市棲霞區(qū)緯地路9號
編:
210000
化:
www.co-bioer.com
網(wǎng)址:
www.cobioer.com/
鋪:
http://m.true-witness.com/st281842/
給他留言
CBP74063ICOS Effector Reporter Cell
ICOS Effector Reporter Cell
參考價 面議
具體成交價以合同協(xié)議為準(zhǔn)
  • 型號 CBP74063
  • 品牌 cobioer/科佰生物
  • 廠商性質(zhì) 代理商
  • 所在地 南京市

更新時間:2022-07-28 14:00:16瀏覽次數(shù):611

聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!

【簡單介紹】
供貨周期 現(xiàn)貨 規(guī)格 T-25 Flask
貨號 CBP74063 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
主要用途 僅限科研使用
ICOS Effector Reporter Cell,凍存條件:90% FBS+10% DMSO;
【詳細(xì)說明】

ICOS Effector Reporter Cell

CBP74063
I. Background
ICOS is a costimulatory molecule of the CD28 cell surface receptor superfamily that is expressed on activated T-cells. ICOS is involved in T-cell responses upon binding with its ligand, ICOSL (also known as B7-H2, CD275), which is normally expressed on B-cells, dendritic cells and monocytes.
II. Description

ICOS expression confers an activated phenotype and a strong suppressive capacity to intra-tumoral regulatory T-cells. The ICOS/ICOSL pathway is a key target for cancer immunotherapy.

III. Introduction
Expressed gene:ICOS
Stability:32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Synonym(s):T-cell costimulator, CD278
Freeze Medium:90% FBS+10% DMSO
Culture Medium:RPMI-1640+10%FBS+800ug/ml hygromycin+10ug/ml blasticidin
Mycoplasma Testing:Negative
Storage:Liquid nitrogen
Application(s):Functional(Report Gene) Assay

IV. Representative Data

CBP74063.png




Figure 1. Dose response of Anti-lCOS Ab in ICOS Effector Reporter Cells(C5).






產(chǎn)品對比 產(chǎn)品對比 二維碼 在線交流

掃一掃訪問手機商鋪

對比框

在線留言